LEARN MORE
Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.
LEARN MOREPress Releases
Events
International Epilepsy Congress
Cantor Fitzgerald's Global Healthcare Conference
Clinical Trials
Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.
Follow Us on Twitter
Ganaxolone is being studied in women who suffer from postpartum depression.... wanna know how it works? t.co/8ouWuWHa7u #PPD